HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,254 | -94.5% | 14 | -94.4% | 0.00% | – |
| Q2 2020 | $23,000 | +35.3% | 252 | +44.0% | 0.00% | – |
| Q1 2020 | $17,000 | +142.9% | 175 | +14.4% | 0.00% | – |
| Q1 2016 | $7,000 | +16.7% | 153 | -18.6% | 0.00% | – |
| Q4 2015 | $6,000 | +20.0% | 188 | +22.9% | 0.00% | – |
| Q3 2015 | $5,000 | -16.7% | 153 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | -14.3% | 153 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | +133.3% | 153 | +104.0% | 0.00% | – |
| Q4 2014 | $3,000 | -87.5% | 75 | -79.2% | 0.00% | -100.0% |
| Q1 2011 | $24,000 | +4.3% | 360 | 0.0% | 0.00% | 0.0% |
| Q4 2010 | $23,000 | +9.5% | 360 | 0.0% | 0.00% | 0.0% |
| Q3 2010 | $21,000 | +10.5% | 360 | 0.0% | 0.00% | 0.0% |
| Q2 2010 | $19,000 | -64.2% | 360 | -61.0% | 0.00% | -50.0% |
| Q1 2010 | $53,000 | +3.9% | 922 | 0.0% | 0.00% | 0.0% |
| Q4 2009 | $51,000 | -23.9% | 922 | -22.5% | 0.00% | -33.3% |
| Q3 2009 | $67,000 | -1.5% | 1,190 | -0.7% | 0.00% | 0.0% |
| Q2 2009 | $68,000 | -5.6% | 1,198 | -8.3% | 0.00% | -25.0% |
| Q1 2009 | $72,000 | – | 1,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |